Multicenter, nonrandomized, open-label Phase 1b study of FP-1039/GSK3052230 with chemotherapy: Results in malignant pleural mesothelioma (MPM) Meeting Abstract
| Authors: | Trigo Perez, J. M.; van Brummelen, E.; Levchenko, E.; Domine Gomez, M.; Fennell, D. A.; Kindler, H. L.; Viteri, S.; Gadgeel, S.; Garrido Lopez, P.; Kostorov, V.; Morgensztern, D.; Orlov, S.; Paik, P. K.; Vansteenkiste, J. F.; Wang, X.; Sharabidze, A.; Deyoung, M. P.; Baker, K. P.; Yan, L.; Mitrica, I. |
| Abstract Title: | Multicenter, nonrandomized, open-label Phase 1b study of FP-1039/GSK3052230 with chemotherapy: Results in malignant pleural mesothelioma (MPM) |
| Meeting Title: | 42nd ESMO Congress (ESMO 2017) |
| Journal Title: | Annals of Oncology |
| Volume: | 28 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2017 Sep 8-12 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-09-01 |
| Start Page: | mdx389.001 |
| Language: | English |
| ACCESSION: | WOS:000411324004131 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdx389.001 |
| Notes: | Meeting Abstract: 16160 -- Appears on pages 568-569 of the abstract book -- Source: Wos |
